scholarly journals Evaluating the Effectiveness of Switching to Insulin Degludec from Other Basal Insulins in a Real-World Canadian Population with Type 1 or Type 2 Diabetes: The CAN-TREAT Study

2021 ◽  
Author(s):  
Stewart B. Harris ◽  
Olubukola Ajala ◽  
Basel Bari ◽  
Joanne Liutkus ◽  
Jina Hahn ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Real World ◽  
Insulin Degludec ◽  
Canadian Population

scholarly journals Real-world cost-effectiveness of insulin degludec in type 1 and type 2 diabetes mellitus from a Swedish 1-year and long-term perspective

2020 ◽  
Vol 23 (11) ◽  
pp. 1311-1320
Author(s):  
Johan Jendle ◽  
Åsa Ericsson ◽  
Bertil Ekman ◽  
Stefan Sjöberg ◽  
Jens Gundgaard ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Cost Effectiveness ◽  
Real World ◽  
Insulin Degludec

scholarly journals PDB23 SWITCHING TO INSULIN DEGLUDEC IS A COST-SAVING THERAPY FOR PATIENTS WITH TYPE 1 AND TYPE 2 DIABETES IN THE SWEDISH SETTING BASED ON REAL WORLD DATA

2019 ◽  
Vol 22 ◽  
pp. S575-S576
Author(s):  
J. Jendle ◽  
M. Thunander ◽  
B. Ekman ◽  
S. Sjöberg ◽  
Å. Ericsson ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Cost Saving ◽  
Real World ◽  
Insulin Degludec ◽  
Real World Data ◽  
World Data

Switching to Insulin Degludec from Insulin Glargine U100 Improves Glycemic Control in People with Type 1 (T1D) or Type 2 diabetes (T2D) in a Real-World Setting

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 1014-P
Author(s):  
SOREN T. KNUDSEN ◽  
NIKOLAOS TENTOLOURIS ◽  
BERND SCHULTES ◽  
ANNUNZIATA LAPOLLA ◽  
MARKUS EIDENMUELLER ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Glycemic Control ◽  
Insulin Glargine ◽  
Real World ◽  
Insulin Degludec ◽  
Real World Setting

126-LB: Glycemic Outcomes for People with Type 1 and Type 2 Diabetes Using Control-IQ Technology: Real-World Data from Early Adopters

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 126-LB ◽  
Author(s):  
STEPHANIE HABIF ◽  
ALEXANDRA CONSTANTIN ◽  
LARS MUELLER ◽  
HARSIMRAN SINGH
Keyword(s):  
Type 2 Diabetes ◽  
Real World ◽  
Real World Data ◽  
Early Adopters ◽  
World Data ◽  
Glycemic Outcomes

710-P: Real-World Evaluation of Glycemic Outcomes by Prior Therapy for People with Type 1 and Type 2 Diabetes Onboarding to Control-IQ Technology

Diabetes ◽  
2021 ◽  
Vol 70 (Supplement 1) ◽  
pp. 710-P
Author(s):  
JOHN W. MORBERG ◽  
HARSIMRAN SINGH ◽  
MOLLY MCELWEE-MALLOY ◽  
STEPHANIE HABIF ◽  
ALEXANDRA CONSTANTIN
Keyword(s):  
Type 2 Diabetes ◽  
Real World ◽  
Prior Therapy ◽  
Glycemic Outcomes
Sign in / Sign up

Export Citation Format

Share Document